USPTO 2015–2025 USPTO PatentsView US Corporation

Abb Vie Inc.

USPTO PatentsView assignee record - 604 granted patents across 53 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

604

Total patents granted

CPC technology areas

17.7

Avg claims per patent

-71%

5-year filing velocity

The verdict

Abb holds 604 US patents across 53 technology areas, rank #759 of 50,000 tracked assignees.

#759
of 50,000 US assignees by volume: Top 2%
by Innovation Score (63.2/100): 17.7
avg claims per patent: -71%
filing velocity, last 5 yrs

Portfolio overview

Abb Vie Inc. has been granted 604 US utility patents between 2015 and 2025, placing Abb Vie Inc. at rank #759 across all assignees tracked by PlainPatent. This portfolio spans 53 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.7 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Abb Vie Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Abb sits between Essilor International (606 patents, rank #755) and Ethicon Endo-surgery, Inc. (601 patents, rank #763) - the closest US assignees by grant volume. The composite Innovation Score of 63.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 136 grants, compared with 468 in the 2015–2019 window, a -71% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Abb Vie Inc.'s 17.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 53 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Abb Vie Inc. against peers pursuing similar technology classes.

Essilor Internati…

606
Sysmex

606
Carl Zeiss Micros…

605
Parker-hannifin

605
SAS Institute

604
Abb Vie ◀

604
DIC

602
Maxlinear

602
Ethicon Endo-surg…

601

What this shows Abb holds 604 patents at rank #759, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abb

By rank, the assignees closest to #759 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Abb's primary technology class.

Abb's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abb Vie Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	150	24.8%
2016	120	19.9%
2017	82	13.6%
2018	75	12.4%
2019	41	6.8%
2020	34	5.6%
2021	18	3.0%
2022	21	3.5%
2023	30	5.0%
2024	25	4.1%
2025	8	1.3%

Which technologies does Abb Vie Inc. patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 391

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 333

C07D - HETEROCYCLIC COMPOUNDS 284

C07K - PEPTIDES 162

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 64

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 53

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 51

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 39

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 36

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 35

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 30

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 18

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 13

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 12

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 12

Top 15 of 53 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#759

Across all tracked assignees

Innovation Score

63.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Abb Vie Inc. hold?

Abb Vie Inc. holds 604 US granted patents filed between 2015 and 2025, spanning 53 technology areas.

What is Abb Vie Inc.'s Innovation Score?

Abb Vie Inc. has an Innovation Score of 63.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abb Vie Inc. focus on?

Abb Vie Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 391 patents. The company has filed patents in 53 CPC subclasses total.

Is Abb Vie Inc.'s patent filing rate increasing or decreasing?

Abb Vie Inc.'s recent filing velocity is -71% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Abb Vie Inc.'s patents?

Abb Vie Inc.'s patents average 17.7 claims each. This falls within the standard range, providing solid legal coverage.

How is the Abb Vie Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Abb's 604 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Abb ranks #759 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.